BlackRock, Inc. (BLK) 13D/13G Filings for Rigel Pharmaceuticals, Inc. (RIGL)

BlackRock, Inc. 13D and 13G filings for Rigel Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-04-17
09:35 am
Sale		 2025-03-31 13G Rigel Pharmaceuticals, Inc.
RIGL		 BlackRock Inc.
BLK		 1,381,983
7.700%		 -366,124decrease
(-20.94%)		 Filing
2025-02-05
1:23 pm
Purchase		 2024-12-31 13G Rigel Pharmaceuticals, Inc.
RIGL		 BlackRock Inc.
BLK		 1,748,107
9.900%		 1,748,107increase
(New Position)		 Filing